U.S. Representatives Kevin Brady (R-TX) and Lois Capps (D-CA) introduced the Pulmonary Hypertension Research and Diagnosis Act yesterday, bi-partisan legislation which will help improve accurate early diagnosis and appropriate treatment of patients who suffer from Pulmonary Hypertension (PH).
"Pulmonary Hypertension is a terrible and often fatal disease which affects thousands of Americans, most of them young women," said Brady. "When we've invested in research in the past, we've seen meaningful results. And we've discovered that an early diagnosis is the best way to make sure that current treatments are successful."
Brady noted that there are medications available that would help, but the longer it takes for the disease to be diagnosed, the less helpful the medications become, "so, early diagnosis is the real key for a positive prognosis."
This legislation will allow federal public health agencies to work together, deciding how to most effectively leverage available resources to identify and address critical health care barriers impacting early diagnosis and treatment for patients with PH.
"Pulmonary Hypertension can be a devastating diagnosis for patients and families and with only limited treatments, it is critical that we do all we can to leverage our resources. Our bipartisan bill would do just that by making smart, coordinated federal investments and providing hope to all those with PH," said Congresswoman Capps.
"I thank my colleague, Representative Lois Capps, for her dedication to this issue and willingness to reach across the aisle in order to work on this bi-partisan, budget neutral legislation that will help save American lives," Brady concluded.